844 IN VITRO CHARACTERIZATION OF THE PAN-GENOTYPE ACTIVITY OF THE HCV NS3/4A PROTEASE INHIBITORS BOCEPREVIR AND TELAPREVIR

MLA

M. Treitel, et al. “844 in Vitro Characterization of the Pan-Genotype Activity of the Hcv Ns3/4A Protease Inhibitors Boceprevir and Telaprevir.” Journal of Hepatology, vol. 56, Apr. 2012, p. S329. EBSCOhost, https://doi.org/10.1016/s0168-8278(12)60856-3.

APA

M. Treitel, G. Zhuyan, Daria J. Hazuda, Anita Y. M. Howe, Rumin Zhang, Stephanie Curry, R.A. Ogert, Patricia McMonagle, Richard J. O. Barnard, J. Strizki, John A. Howe, Robert Chase, Donald J. Graham, & Frederick C. Lahser. (2012). 844 in Vitro Characterization of the Pan-Genotype Activity of the Hcv Ns3/4A Protease Inhibitors Boceprevir and Telaprevir. Journal of Hepatology, 56, S329. https://doi.org/10.1016/s0168-8278(12)60856-3

Chicago

M. Treitel, G. Zhuyan, Daria J. Hazuda, Anita Y. M. Howe, Rumin Zhang, Stephanie Curry, R.A. Ogert, et al. 2012. “844 in Vitro Characterization of the Pan-Genotype Activity of the Hcv Ns3/4A Protease Inhibitors Boceprevir and Telaprevir.” Journal of Hepatology 56 (April): S329. doi:10.1016/s0168-8278(12)60856-3.